Jessica R Durkee-Shock, M.D.
National Institute of Allergy and Infectious Diseases (NIAID)
4
4
2
N/A
0
15
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jessie Alexander, MD
Stanford University
Shared therapeutic areas:
Mitchell Cairo, MD
New York Medical College
Shared therapeutic areas:
Helen Heslop, MD
Baylor College of Medicine
Shared therapeutic areas:
Catherine Bollard, MD
Children's National Research Institute
Shared therapeutic areas:
Christopher J Melani, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Stephanie Staras, PhD
University of Florida
Shared therapeutic areas:
Lung-Ji Chang, PhD
Shenzhen Geno-Immune Medical Institute
Shared therapeutic areas:
Margaret M Madeleine, PhD, MPH
Fred Hutchinson Cancer Center
Shared therapeutic areas:
Allan Hildesheim, Ph.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Gill Woodall, PhD
Klein Buendel, Inc.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection
Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons
Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults
The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
All 4 trials loaded